Consistent with this, histological staining for tartrate resistant acid phosphatase (TRAP) activity, a marker of active osteoclasts, showed that treatment with 1D11 significantly reduced the number of TRAP-positive osteoclasts located at the tumor:bone interface (Figure 6D). Here, ACP5 is linked to neoplasm.